|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Cash | |||||||||
| Due from related party | |||||||||
| Prepaid expenses | |||||||||
| Total Current Assets | |||||||||
| Deferred offering costs | |||||||||
| Prepaid expense – noncurrent | |||||||||
| Cash and investments held in Trust Account | |||||||||
| TOTAL ASSETS | |||||||||
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | |||||||||
| Accrued expenses | |||||||||
| Accounts payable and accrued expenses | |||||||||
| Due to related parties | |||||||||
| Advance from related party | |||||||||
| Promissory note – related party | |||||||||
| Excise tax payable | |||||||||
| Income tax payable | |||||||||
| Total Current Liabilities | |||||||||
| TOTAL LIABILITIES | |||||||||
| Class A common stock subject to possible redemption, $0.0001 par value; 1,335,696 and 11,500,000 shares at a redemption value of $10.91 and $10.29 per share at September 30, 2023 and December 31, 2022, respectively | |||||||||
| STOCKHOLDERS’ DEFICIT: | |||||||||
| Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding | |||||||||
| Common stock, value | |||||||||
| Common Class A | |||||||||
| Common Class B | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated deficit | |||||||||
| TOTAL STOCKHOLDERS’ DEFICIT | |||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT |
Loading...
